Challenges in early clinical drug development for ischemia-reperfusion injury in kidney transplantation. (2015)
Attributed to:
MICA: RIP1 kinase inhibition to reduce kidney injury
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1517/17460441.2015.1044967
PubMed Identifier: 25947288
Publication URI: http://europepmc.org/abstract/MED/25947288
Type: Journal Article/Review
Volume: 10
Parent Publication: Expert opinion on drug discovery
Issue: 7
ISSN: 1746-0441